Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neurochemical Effects of Omega-3 Fatty Acids in Adolescents at Risk for Mania
NCT00917501Phase 2Completed
- Sponsor
- University of Cincinnati
- Start
- Jun 2009
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of MAT9001 in major depressive disorder (MDD), sponsored by University of Cincinnati. Started Jun 2009; status: completed.
02
Drugs
MAT9001
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00917501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00917501.